Pohl MA - Search Results

1

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group. Lewis EJ, et al. Among authors: pohl ma. N Engl J Med. 2001 Sep 20;345(12):851-60. doi: 10.1056/NEJMoa011303. N Engl J Med. 2001. PMID: 11565517 Free article. Clinical Trial.

2

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group. Lewis EJ, et al. Among authors: pohl ma. Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Am J Kidney Dis. 2011. PMID: 21872376 Clinical Trial.

3

Pyridorin in type 2 diabetic nephropathy.

Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB; Collaborative Study Group. Lewis EJ, et al. Among authors: pohl ma. J Am Soc Nephrol. 2012 Jan;23(1):131-6. doi: 10.1681/ASN.2011030272. Epub 2011 Oct 27. J Am Soc Nephrol. 2012. PMID: 22034637 Free PMC article. Clinical Trial.

4

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations.

Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ. Pohl MA, et al. J Am Soc Nephrol. 2005 Oct;16(10):3027-37. doi: 10.1681/ASN.2004110919. Epub 2005 Aug 24. J Am Soc Nephrol. 2005. PMID: 16120823 Clinical Trial.

5

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Collaborative Study Group. Berl T, et al. Among authors: pohl m. J Am Soc Nephrol. 2005 Jul;16(7):2170-9. doi: 10.1681/ASN.2004090763. Epub 2005 Jun 1. J Am Soc Nephrol. 2005. PMID: 15930097

6

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group.

Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ. Rodby RA, et al. Among authors: pohl ma. Am J Kidney Dis. 1995 Dec;26(6):904-9. doi: 10.1016/0272-6386(95)90054-3. Am J Kidney Dis. 1995. PMID: 7503064 Clinical Trial.

7

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL; North America Nephrotic Syndrome Study Group. Cattran DC, et al. Among authors: pohl ma. Kidney Int. 2001 Apr;59(4):1484-90. doi: 10.1046/j.1523-1755.2001.0590041484.x. Kidney Int. 2001. PMID: 11260412 Free article. Clinical Trial.

8

Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Pohl MA, Lan SP, Berl T. Pohl MA, et al. Ann Intern Med. 1991 Jun 1;114(11):924-9. doi: 10.7326/0003-4819-114-11-924. Ann Intern Med. 1991. PMID: 2024858 Clinical Trial.

9

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL. Cattran DC, et al. Among authors: pohl ma. Kidney Int. 1999 Dec;56(6):2220-6. doi: 10.1046/j.1523-1755.1999.00778.x. Kidney Int. 1999. PMID: 10594798 Free article. Clinical Trial.

10

Aggressive blood pressure lowering is safe, but benefit is still hard to prove.

Vidt DG, Pohl MA. Vidt DG, et al. Among authors: pohl ma. Cleve Clin J Med. 1999 Feb;66(2):105-11. doi: 10.3949/ccjm.66.2.105. Cleve Clin J Med. 1999. PMID: 9988956 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page